Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2461 in advanced solid tumors
NCT00496353Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-2461 in solid tumor, sponsored by Merck & Co.. Started Jun 2007; status: completed.
02
Drugs
MK-2461
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00496353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496353.